Morgan Stanley analyst Aisyah Noor raised the firm’s price target on Medacta Group (MEDGF) to CHF 136 from CHF 135 and keeps an Overweight rating on the shares.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEDGF: